Ethyl 7-bromo-2,2-dimethylheptanoate
Grundinformationen
- CAS
123469-92-1- Standard-SMILES
CCOC(=O)C(C)(C)CCCCCBr- InChIKey
SYRIIFZUZOIRNU-UHFFFAOYSA-N- Summenformel
- C11H21BrO2
- Durchschnittliche Molmasse
- 265,19 g/mol
Namen und Bezeichner
- Bevorzugter Name
- Ethyl 7-bromo-2,2-dimethylheptanoate
- IUPAC
- ethyl 7-bromo-2,2-dimethylheptanoate
- Englischer Name
- Ethyl 7-bromo-2,2-dimethylheptanoate
- Summenformel
- C11H21BrO2
- Molmasse
- 265.19
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
123469-92-1- PubChem CID
- 11265571
- UNII
- PM7RLC2NE9
- EC Number
- 987-015-4
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,7
- Polarare Oberfläche (TPSA)
- 26,3 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 8
- Schwere Atome
- 14
- Formalladung
- 0
- Komplexität
- 167
Physikochemische Eigenschaften
- Siedepunkt
- 106 · 106-108 °C(Press: 0.01 Torr)
- Dichte
- 1.169 · 1.169±0.06 g/cm3(Predicted)
- Dampfdruck
- 0 · 0.0±0.6 mmHg at 25°C
- Brechungsindex
- 1.463 · 1.463
- Flammpunkt
- 146.4 · 146.4±13.0 °C
- storage temp.
- Store at room temperature
- InChI
- InChI=1S/C11H21BrO2/c1-4-14-10(13)11(2,3)8-6-5-7-9-12/h4-9H2,1-3H3
- InChIKey
- SYRIIFZUZOIRNU-UHFFFAOYSA-N
- SMILES
- C(OCC)(=O)C(C)(C)CCCCCBr
- LogP
- 3.92 · 3.92
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P264, P264+P265, P273, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Sicherheitsdaten
- ridadr
- UN2810
- hs_code
- 2915907098
- hazard_class
- 6.1
Chemie und Industrie
Anwendungen
BeschreibungEthyl 7-bromo-2,2-dimethylheptanoate is an important raw material in the synthesis route of bepetidic acid. Bempedoic acid, whose chemical name is 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid, also known as ETC-1002, is a new type of lipid developed by the American EsperionTherapeutic company Quality regulation small molecule drugs. As one of the company's main drug candidates, its targets are liver adenosine triphosphate-citrate lyase (ACL) and adenosine monophosphate-activated protein kinase (AMPK).
VerwendenEthyl-2,2-dimethyl-7-bromoheptanoate can be used as an intermediate in organic synthesis, mainly used in laboratory research and development and chemical production processes.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…